Successful Use of Tildrakizumab for Treatment of Palmoplantar Pustulosis
Palmoplantar PustulosisPalmoplantar pustulosis (PPP) is a rare, recurrent skin disorder that presents a major challenge to clinical therapy. JDD author Danilo C. Del Campo, MD, FAAD reports a case of a 69-year-old woman with a 20-year history of psoriasis with skin manifestations and clinical and pathologic features consistent with PPP. After intolerance to apremilast and unsuccessful use of topical corticosteroids and …
Palmoplantar Pustulosis
Rosacea in Patients with Skin of Color: Not Common, But Certainly Not Rare
rosaceaRosacea is defined by facial erythema and telangiectasias, two features that are more difficult to appreciate in patients with skin of color. To refine our ability to diagnose rosacea in all skin types, on day two of the 2021 Skin of Color Update virtual conference, we had an informative, evidence-based lecture, “Recognizing, Diagnosing, and Treating Rosacea in Patients with Skin of Color,” by …
rosacea
Skincare for Cancer Patients and Survivors: US Cutaneous Oncodermatology Management (USCOM) – A Practical Algorithm
  The US Cutaneous Oncodermatology Management (USCOM) project aims to improve cancer patients’ and survivors’ quality of life by offering tools for preventing and managing cancer treatment-related cutaneous toxicities. The USCOM panel of clinicians who treat cancer treatment-related cutaneous CAEs developed, discussed, and reached a consensus on statements and an evidence-based algo …
Cosmeceutical Recommendations for Diverse Skin Types
cosmeceuticalsAt the 2021 Skin of Color Update, Dr. Heather Woolery-Lloyd, Director of the Skin of Color Division at the University of Miami Department of Dermatology,  delivered an excellent talk on cosmeceutical recommendations for patients with diverse skin types, a personal favorite subject of hers. Catch the pearls of her talk here! Hot Topics  in Cosmeceuticals Topical Cannabinoids – The skin has it …
cosmeceuticals
PAH Post-Cryolipolysis | The Expert Weighs In
PAHSELF magazine recently covered supermodel Linda Evangelista’s recent admission that she developed paradoxical adipose hyperplasia (PAH) after undergoing cryolipolysis. The article mentions a 2017 Journal of Drugs in Dermatology review that found the incidence of PAH post-cryolipolysis may be higher than previously reported. I reached out to one of the authors of the review, Jared Jagdeo, MD, …
PAH
error

Enjoy this blog? Please spread the word :)